Similarly, IMT was also increased in CD19(+)CD5(−) B cells ≤0.05 × 109 /L in the total cohort (1.05 ± 0.18 vs. 0.97 ± 0.16, P = 0.006) and CKD group (1.08 ± 0.19 vs. 0.99 ± 0.16, P = 0.004). The gene discussed is CD19; the disease is chronic kidney disease.